Breaking News Instant updates and real-time market news.

TROW

T. Rowe Price

$83.18

-0.01 (-0.01%)

, BWXT

BWX Technologies

$53.92

-0.07 (-0.13%)

14:44
08/10/17
08/10
14:44
08/10/17
14:44

T. Rowe Price reports 11.1% passive stake in BWX Technologies

TROW

T. Rowe Price

$83.18

-0.01 (-0.01%)

BWXT

BWX Technologies

$53.92

-0.07 (-0.13%)

TROW T. Rowe Price
$83.18

-0.01 (-0.01%)

07/26/17
FBCO
07/26/17
NO CHANGE
Target $90
FBCO
Neutral
T. Rowe Price price target raised to $90 from $70 at Credit Suisse
Credit Suisse analyst Craig Siegenthaler raised his price target for T. Rowe Price to $90 from $70 following Q2 results, and now forecasts positive net flows in 2017-2019 driven by a rapid improvement in net flow trends in Q2. The analyst reiterates a Neutral rating on the shares.
06/22/17
SBSH
06/22/17
NO CHANGE
SBSH
Waddell & Reed takeover speculation a 'head scratcher,' says Citi
Citi analyst William Katz attributes today's strength in Waddell & Reed (WDR) to a Dealreporter article suggesting that Invesco (IVZ), T. Rowe Price (TROW) and Vanguard may have interest in an acquisition, though he believes such combinations are "strategic non-starters." Both Invesco and T. Rowe offered no comment when contacted, added Katz, who keeps a Sell rating on W&R shares.
05/24/17
UBSW
05/24/17
DOWNGRADE
Target $61
UBSW
Sell
T. Rowe Price downgraded to Sell from Buy at UBS
UBS analyst Brennan Hawken double downgraded T. Rowe Price to Sell from Buy and cut his price target for the shares to $61 from $77. The analyst expects furtehr compression of the company's multiple given 401k litigation risk. While T. Rowe is negatively impacted by the Department of Labor fiduciary rule, the 2010 DOL rule that increased transparency into 401k fees is the "underappreciated threat," Hawken tells investors in a research note. He believes outflows from the company's Target Date Funds are just beginning.
04/26/17
ARGS
04/26/17
DOWNGRADE
ARGS
Hold
T. Rowe Price downgraded to Hold on competitive pressures at Argus
Argus analyst Stephen Biggar downgraded T. Rowe Price to Hold from Buy saying it is facing a number of competitive challenges, including increased outflows as investors move to passive products, reduced fund fees, and likely increased advertising and promotion to retain managed assets. Further, the analyst said 2016 results benefited from lower fee waivers on money market funds that interest rate increases will largely eliminate in 2017.
BWXT BWX Technologies
$53.92

-0.07 (-0.13%)

06/09/17
06/09/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Mindbody (MB) initiated with an Overweight at JPMorgan. 2. Alarm.com (ALRM) initiated with an Outperform at Northland. 3. First Mid-Illinois Bancshares (FMBH) initiated with a Neutral at DA Davidson. 4. Integrated Device (IDTI) initiated with a Buy at Longbow. 5. BWX Technologies (BWXT) initiated with a Neutral at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/09/17
FBCO
06/09/17
INITIATION
Target $51
FBCO
Neutral
BWX Technologies initiated with a Neutral at Credit Suisse
Credit Suisse analyst Robert Springarn initiated BWX Technologies with a Neutral and a $51 price target saying the Navy's ambitious funding plan is nearly reflected in valuation.
04/05/17
RHCO
04/05/17
NO CHANGE
RHCO
Defense stocks likely to be weak in short-term, says SunTrust
SunTrust analyst Michael Ciarmoli says that "ongoing discord" in Washington, including animus over the confirmation of Judge Gorsuch, will cause defense stocks to undergo "short-term selling pressure and multiple compression." The analyst says that the conflict between the parties and clashes over the budget could derail the Trump Administration's defense spending goals. Additionally, he says that a lack of funds could force Congress to cut the funds appropriated to some defense programs. Nevertheless, the analyst is upbeat on the sector over the longer tyerm ,citing the need to update aging equipment and elevated threat levels. He thinks that any short-term weakness should be viewed by longer term investors as a buying opportunity. The analyst keeps Buy ratings on Aerojet Rocketdyne (AJRD), BWX Technologies (BWXT), Kratos Defense (KTOS), Mercury Systems (MRCY), and Orbital ATK (OA),
03/21/17
BOFA
03/21/17
UPGRADE
Target $55
BOFA
Buy
BWX Technologies upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Ronald Epstein upgraded BWX Technologies to Buy and raised its price target to $55 from $43. The analyst said BWX is the sole provider of nuclear reactors to the US Navy and is a significant beneficiary of defense spending to support a 355-ship Navy. Epstein raised his 2016a-2020 sales growth estimate to 8% CAGR from 5% to reflect medium-term Navy shipbuilding opportunities.

TODAY'S FREE FLY STORIES

KSU

Kansas City Southern

$105.80

-0.07 (-0.07%)

17:45
08/18/17
08/18
17:45
08/18/17
17:45
Hot Stocks
Kansas City Southern director Henry Maier buys 3,000 shares »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

RXII

RXi Pharmaceuticals

$0.58

-0.02 (-3.36%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on RXi Pharmaceuticals »

RXi Pharmaceuticals files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WIN

Windstream

$1.98

0.06 (3.13%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Hot Stocks
Windstream CEO acquires 25,381 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$2.44

-0.22 (-8.27%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on CEL-SCI »

CEL-SCI files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRN

Trinity Industries

$28.20

-0.03 (-0.11%)

17:25
08/18/17
08/18
17:25
08/18/17
17:25
Hot Stocks
ValueAct raises stake inTrinity Industries to 11% from 9.8% »

As of this date, ValueAct…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTN

Lpath

17:11
08/18/17
08/18
17:11
08/18/17
17:11
Hot Stocks
Breaking Hot Stocks news story on Lpath »

Stonepine Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGR

Progressive

$48.63

0.12 (0.25%)

17:08
08/18/17
08/18
17:08
08/18/17
17:08
Hot Stocks
Progressive CFO sells 50,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$172.57

-0.32 (-0.19%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Thermo Fisher director sells 11,318 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

SMBC

Southern Missouri Bancorp

$31.18

-0.05 (-0.16%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Southern Missouri Bancorp and Southern Missouri Bancshares to merge »

Southern Missouri Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:58
08/18/17
08/18
16:58
08/18/17
16:58
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ended advisory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says never had…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:56
08/18/17
08/18
16:56
08/18/17
16:56
Hot Stocks
Icahn no longer special advisor to President Trump on regulatory reform issues »

Carl Icahn, founder of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:55
08/18/17
08/18
16:55
08/18/17
16:55
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:49
08/18/17
08/18
16:49
08/18/17
16:49
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$30.38

0.76 (2.57%)

16:48
08/18/17
08/18
16:48
08/18/17
16:48
Hot Stocks
Micron director sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

INSY

Insys Therapeutics

$9.17

-0.11 (-1.19%)

16:42
08/18/17
08/18
16:42
08/18/17
16:42
Hot Stocks
Insys agrees to pay $4.45M to settle opioid marketing suit »

Illinois Attorney General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTX

Akari Therapeutics

16:34
08/18/17
08/18
16:34
08/18/17
16:34
Syndicate
Breaking Syndicate news story on Akari Therapeutics »

Akari Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JMBA

Jamba

$9.11

-0.04 (-0.44%)

16:32
08/18/17
08/18
16:32
08/18/17
16:32
Hot Stocks
Jamba receives expected letter from Nasdaq »

Jamba, Inc. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIL

Hill International

$4.50

0.2 (4.65%)

16:31
08/18/17
08/18
16:31
08/18/17
16:31
Hot Stocks
Hill International receives NYSE notice regarding late Form 10-Q filing »

Hill International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$55.65

-0.47 (-0.84%)

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Periodicals
Target ends relationship with food startup Hampton Creek, Bloomberg says »

After an internal review,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Options
Preliminary option volume of 23.2M today »

Preliminary option volume…

NBEV

New Age Beverages

$3.51

-0.49 (-12.25%)

16:29
08/18/17
08/18
16:29
08/18/17
16:29
Hot Stocks
New Age Beverages director sells nearly 42,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

, ESV

Ensco

$4.28

0.12 (2.88%)

16:24
08/18/17
08/18
16:24
08/18/17
16:24
Hot Stocks
Atwood Oceanics, Ensco file proxy materials in connection with pending merger »

Ensco (ESV) and Atwood…

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

ESV

Ensco

$4.28

0.12 (2.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$83.76

-0.1 (-0.12%)

16:23
08/18/17
08/18
16:23
08/18/17
16:23
Periodicals
Nestle faces potential fraud suit over Poland Spring marketing, WSJ says »

Nestle is facing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.